Literature DB >> 26513765

Central nervous system and muscle involvement in dengue patients: A study from a tertiary care center.

Usha Kant Misra1, Jayantee Kalita2, Vinita Elizabeth Mani2, Prashant Singh Chauhan2, Pankaj Kumar2.   

Abstract

BACKGROUND: Neurological involvement in dengue virus (DENV) infection is being increasingly reported. There is paucity of studies evaluating the relative frequency of central nervous system (CNS) and muscle involvement in dengue.
OBJECTIVES: To evaluate the frequency and prognosis of neurological and muscle involvement in dengue, and correlate these with dengue subtypes. STUDY
DESIGN: Consecutive dengue patients were included, and their clinical features, laboratory investigations and cerebrospinal fluid (CSF) findings were recorded. Cranial MRI was done in unconscious patients and electromyography and nerve conduction study in patients with flaccid weakness. Patients were categorized into encephalopathy, encephalitis, immune mediated and dengue associated muscle dysfunction (DAMD). Outcome at 1 month and its predictors were evaluated.
RESULTS: 116 patients aged 5-70 years were included; 82 had dengue fever (DF), 18 had dengue hemorrhagic fever (DHF), and 16 had dengue shock syndrome (DSS). Neurological manifestations were present in 92 (79%); encephalopathy in 17 (15%), encephalitis in 22 (19%), transverse myelitis in 1 (1%) and DAMD in 52 (45%) patients. Central nervous system (CNS) involvement was commoner in DHF/DSS compared to DF (44% vs 26%). 10 patients with CNS involvement died versus 1 with DAMD. The patients in the CNS group had more frequent hypotension, renal dysfunction and respiratory failure compared to the DAMD group, and had worse outcome. DENV2 and DENV3 were the commonest serotypes, but serotypes did not differ between CNS and DAMD groups.
CONCLUSIONS: DAMD is commoner than CNS involvement in dengue. CNS involvement however, is associated with more serious illness and predicts poorer outcome.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Dengue; Encephalitis; Encephalopathy; Myopathy; Outcome; Serotype; Transverse myelitis

Mesh:

Year:  2015        PMID: 26513765     DOI: 10.1016/j.jcv.2015.08.021

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  14 in total

Review 1.  Beyond thrombocytopaenia, haemorrhage and shock: the expanded dengue syndrome.

Authors:  Senaka Rajapakse; Milanka Wattegama; Praveen Weeratunga; P Chathurani Sigera; Sumadhya Deepika Fernando
Journal:  Pathog Glob Health       Date:  2018-12-03       Impact factor: 2.894

2.  Case Report: Dengue Hemorrhagic Fever with Ischemic Stroke.

Authors:  Basnayake Wasala Mudiyanselage Kumarini Eranthika Basnayake; Kaluachchi Gamage Samanthi Kumari Somaratne; Chathuri Udeshika Goonetilleke; Pattiniya Markkala Yasoma Indrani Tilakaratna; Udaya Kumara Ranawaka
Journal:  Am J Trop Med Hyg       Date:  2021-11-15       Impact factor: 2.345

3.  Carbohydrates: Binding Sites and Potential Drug Targets for Neural-Affecting Pathogens.

Authors:  Cara-Lynne Schengrund
Journal:  Adv Neurobiol       Date:  2023

4.  Transverse Myelitis as an Unusual Complication of Dengue Fever.

Authors:  Mânlio Tasso de Oliveira Mota; Cássia Fernanda Estofolete; Nathalia Zini; Ana Carolina Bernardes Terzian; Delzi Vinha Nunes Gongora; Irineu Luiz Maia; Maurício Lacerda Nogueira
Journal:  Am J Trop Med Hyg       Date:  2016-12-12       Impact factor: 2.345

5.  Isolation and complete genome analysis of neurotropic dengue virus serotype 3 from the cerebrospinal fluid of an encephalitis patient.

Authors:  Rama Dhenni; Mulya Rahma Karyanti; Nina Dwi Putri; Benediktus Yohan; Frilasita A Yudhaputri; Chairin Nisa Ma'roef; Araniy Fadhilah; Aditya Perkasa; Restuadi Restuadi; Hidayat Trimarsanto; Irawan Mangunatmadja; Jeremy P Ledermann; Ronald Rosenberg; Ann M Powers; Khin Saw Aye Myint; R Tedjo Sasmono
Journal:  PLoS Negl Trop Dis       Date:  2018-01-12

6.  Complete genome analysis and characterization of neurotropic dengue virus 2 cosmopolitan genotype isolated from the cerebrospinal fluid of encephalitis patients.

Authors:  Mya Myat Ngwe Tun; Rohitha Muthugala; Takeshi Nabeshima; Aung Min Soe; Shyam Prakash Dumre; Lakmali Rajamanthri; Dulani Jayawardana; Shanthi Attanayake; Shingo Inoue; Kouichi Morita
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

7.  Clinico-epidemiological Study of Viral Acute Encephalitis Syndrome Cases and Comparison to Nonviral Cases in Children from Eastern India.

Authors:  Sandeep Kumar Tripathy; Pravakar Mishra; Bhagirathi Dwibedi; Lipsa Priyadarshini; Rashmi Ranjan Das
Journal:  J Glob Infect Dis       Date:  2019 Jan-Mar

Review 8.  Neurological Manifestations of Dengue Infection.

Authors:  Guo-Hong Li; Zhi-Jie Ning; Yi-Ming Liu; Xiao-Hong Li
Journal:  Front Cell Infect Microbiol       Date:  2017-10-25       Impact factor: 5.293

Review 9.  Dengue infection in India: A systematic review and meta-analysis.

Authors:  Parasuraman Ganeshkumar; Manoj V Murhekar; Veeraraghavadoss Poornima; Velusamy Saravanakumar; Krishnendu Sukumaran; Anandan Anandaselvasankar; Denny John; Sanjay M Mehendale
Journal:  PLoS Negl Trop Dis       Date:  2018-07-16

10.  Development of standard clinical endpoints for use in dengue interventional trials.

Authors:  Kay M Tomashek; Bridget Wills; Lucy Chai See Lum; Laurent Thomas; Anna Durbin; Yee-Sin Leo; Norma de Bosch; Elsa Rojas; Kim Hendrickx; Martin Erpicum; Liane Agulto; Thomas Jaenisch; Hasitha Tissera; Piyarat Suntarattiwong; Beth Ann Collers; Derek Wallace; Alexander C Schmidt; Alexander Precioso; Federico Narvaez; Stephen J Thomas; Robert Edelman; João Bosco Siqueira; M Cristina Cassetti; Walla Dempsey; Duane J Gubler
Journal:  PLoS Negl Trop Dis       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.